Advertisement

Abbott wins FDA approval for its next-generation Omnilink Elite balloon-expandable peripheral stent.

Abbott logo

Abbott (NYSE:ABT) won FDA approval for the latest in its line of peripheral vascular intervention devices, the Omnilink Elite balloon-expandable stent system.

The Omnilink Elite won indication for treatment of atherosclerotic iliac artery lesions, a condition that affects the lower extremities and can result in chronic pain, difficulty with walking and may lead to permanent disability, according to a press release.

The new stent system is based on the design of Abbott's Multi-Link coronary stents, but is made with a cobalt-chromium alloy that is stronger than stainless steel and more easily visible in imaging, according to the company.

Advertisement
Advertisement